Each month, we release new features, improvements, and fixes across the Panaseer platform. Here’s a summary of what’s new in this month’s release.
New features
Investigate and remediate quickly with MetricIQ
Panaseer’s MetricIQ empowers security teams to turn complex metric data into actionable insight. Instead of manually deciding which metric changes require attention and what action to take, you can quickly understand the significance of changes and receive clear recommendations on how to respond, all grounded in the organization’s own data and security best practices.
Accessing MetricIQ from a dashboard
Click the MetricIQ button to highlight trends, patterns, and notable changes. MetricIQ provides instant, actionable visibility into key risks to drive confident decisions and reduce exposure.
A metric summary and suggested remediation actions
Refer to Investigate and remediate quickly with MetricIQ for more information.
Feature enhancements
CRI Profile v2.1
We have released a CRI Profile v2.1 dashboard, which replaces v2.0 in the Cyber Framework Catalog. Metrics and control checks are now tagged with their relevant CRI Profile v2.1 tags.
This enhancement reduces the complexity of regulatory compliance, streamlines audit preparation, and supports alignment with global cyber standards.
Vulnerability exceptions improvements
We have enhanced support for vulnerability exceptions management in the Vulnerability Analytics Pack. Depending on the specific data sources and implementation, exception data from a separate source can be mapped to detections from a vulnerability management tool and surfaced in dashboards.
For instance, a financial institution may use Tenable to scan assets and detect vulnerabilities, and ServiceNow Vulnerability Response to manage SLA and exceptions in vulnerability handling. With the new mapping capability, these exceptions from ServiceNow Vulnerability Response could be mapped in Panaseer to the original detections from Tenable.
Please contact your Customer Success representative for more details.
Comments
0 comments
Please sign in to leave a comment.